Vaccines
COVID-19 Omicron Vaccine Study for Infants and Children 6 Months through 23 months
Cincinnati Children’s is conducting a research study, sometimes known as a clinical trial or clinical study, to learn about the safety and duration of protection of BNT162b Omicron KP.2 vaccine in children 6 months through 23 months to protect against COVID-19. COVID-19 is a respiratory diseas ...More
COVID-19 Vaccine Study for Infants and Children 6 Months to 4 Years Old
Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to learn more about how often children develop a fever when they receive a COVID-19 vaccine on the same day with their other routine childhood vaccines versus when they receive it 1 to 3 wee ...More
Healthy Participant Study for Adults 18 to 49 Years Old
We want to learn more about Enterotoxigenic Escherichia coli (ETEC), a common bacterial cause of diarrhea worldwide. Knowledge from this study may be helpful in developing ETEC vaccines in the future. ...More
RSV Nasal Vaccine Study For Infants and Children
Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to learn if an RSV (respiratory syncytial virus) study nasal vaccine is safe and could offer protection from serious RSV disease. RSV is a common respiratory virus that can be very serious fo ...More
RSV Nasal Vaccine Study For Infants and Children
Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to learn if an RSV (respiratory syncytial virus) study nasal vaccine is safe and could offer protection from serious RSV disease. RSV is a common respiratory virus that can be very serious fo ...More
RSV Vaccine Study for Pregnant Adults and their Infants
Cincinnati Children’s is conducting a research study, sometimes known as a clinical trial or clinical study, to learn about the safety and duration of protection of the licensed RSV Vaccine ABRYSVO in pregnant people and the licensed RSV antibody BEYFORTUS (nirsevimab) in infants. RSV (also c ...More
RSV Vaccine Study for Pregnant People 18-45 years and their Infants
Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to learn about the safety and duration of protection of the licensed RSV Vaccine ABRYSVO in pregnant people and the licensed RSV antibody BEYFORTUS (nirsevimab) in infants. RSV (also called ...More
Contact Us
Adult Participants or Parents of Participants:
Cincinnati Children’s is involved in research because it is very important to understanding diseases and developing ways to prevent and treat health problems in children, as well as adults. Learn more about how you can help. Contact us at clinicalstudies@cchmc.org or 513-636-0098. Or, enroll in our database to be notified about future studies by completing an online sign up form.
Sponsors and Investigators:
The Office for Clinical and Translational Research at Cincinnati Children’s provides sponsors and investigators with comprehensive support services, research tools, personnel and facilities to conduct or facilitate pediatric and adult clinical research studies. Contact us at OCTR@cchmc.org or 513-636-0314.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
